NFSG
KYNB

Newbridge Financial Services Group’s Kyntra Bio KYNB Stock Holding History

Newbridge Financial Services Group’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-370
Closed -$8.2K – 1214
2023
Q4 		$8.2K Sell
370
-1
-0.3% -$15 ﹤0.01% 780
2023
Q3 		$8.01K Sell
371
-42
-10% -$1.65K ﹤0.01% 863
2023
Q2 		$27.9K Sell
413
-128
-24% -$52.9K 0.01% 596
2023
Q1 		$253K Hold
541
– – 0.13% 158
2022
Q4 		$217K Sell
541
-270
-33% -$103K 0.13% 168
2022
Q3 		$264K Buy
811
+70
+9% +$22.5K 0.16% 147
2022
Q2 		$196K Hold
741
– – 0.12% 169
2022
Q1 		$223K Hold
741
– – 0.11% 179
2021
Q4 		$261K Buy
741
+740
+74,000% +$230K 0.12% 167
2021
Q3 		$1K Hold
1
– – ﹤0.01% 1254
2021
Q2 		$1K Hold
1
– – ﹤0.01% 1351
2021
Q1 		$1K Buy
+1
New +$1.06K ﹤0.01% 1268

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Newbridge Financial Services Group's KYNB Position: Q1 2024 in Review

Newbridge Financial Services Group sold out of Kyntra Bio (KYNB) in Q1 2024, closing a stake of 370 shares — an estimated $8.2K sold.

Newbridge Financial Services Group first reported a position in KYNB in Q1 2021 and held it in 12 quarters. The position peaked at $264K in Q3 2022. 112 funds tracked by Wall St. Rank hold KYNB as of Q1 2024.

  • Newbridge Financial Services Group reported no remaining Kyntra Bio position as of Q1 2024 after selling out during the quarter.
  • Newbridge Financial Services Group sold 370 Kyntra Bio shares in Q1 2024, an estimated $8.2K.
  • Newbridge Financial Services Group first reported a position in Kyntra Bio in Q1 2021 and held it in 12 quarters.
  • Newbridge Financial Services Group's Kyntra Bio position peaked at $264K in Q3 2022.
  • 112 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2024.

Based on Newbridge Financial Services Group's 13F filing for Q1 2024, filed 24 Apr 2024.